CTSC KL2 Program
The NIH-funded CTSC supports highly qualified junior faculty to conduct mentored, multidisciplinary, patient-oriented clinical research. Clinical research is defined as (a) patient oriented research conducted with human subjects (or on material of human origin) that includes mechanisms of human disease, therapeutic interventions, clinical trials, and/or development of new technologies; (b) epidemiologic and behavioral studies; (c) health services and outcomes research. The period of support is for 2 years but may extend for up to 3 years.
The goal of the program is to accelerate the career development of promising junior faculty, promoting their development as independent clinical multidisciplinary research investigators. The program will provide selected scholars with a salary of $110,000 plus benefits (up to $145,090 in salary and benefits combined), as well as $25,000 for travel and research expenses each year. Travel to the annual CTSA Translational Science meeting is mandatory in the first two years, and submission of an abstract is required for reimbursement of travel expenses, and submission of an abstract is required for reimbursement of travel expenses. Scholars in the KL2 program will:
- Obtain additional research training through participation in coursework, workshops, and/or individualized programs of study.
- Conduct a rigorous multidisciplinary clinical/patient-oriented research investigation relevant to their research interests.
- Be mentored by senior investigators from diverse backgrounds with a demonstrated track record of successfully developing the careers of junior colleagues.
- Utilize, and participate in, the activities and resources of the UC Davis CTSC, as well as a nation-wide consortium of 60 other NIH-funded CTSA sites. This will include a commitment to presenting their research progress at meetings and in seminars.
Call for Applications - Deadline 12-01-2020 at 10 a.m.
October 2, 2020
Stephanie Crossen, a pediatric endocrinologist and assistant professor of clinical pediatrics at UC Davis Health will begin a four-year K23 training award funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
Dr. Crossen will study several ways to leverage telehealth and connected health technology to improve care delivery and outcomes for children and adolescents with type 1 diabetes. Type 1 diabetes is a chronic condition with onset in childhood and requires close self-monitoring as well as frequent contact with a specialized medical team.
October 2, 2020
UC Davis CTSC KL2 Scholar Jennifer Rosenthal Transitions to K23 Award
Jennifer Rosenthal, assistant professor of clinical pediatrics, will begin a four-year K23 Mentored Patient-Oriented Research Career Development Award funded by the National Institute of Child Health and Human Development (NICHD) to study pediatric interfacility transfers.
Pediatric interfacility transfers are frequent but poorly studied events. Dr. Rosenthal’s project, “Telemedicine Consultations to Improve Care Quality of Pediatric Hospital-to-Hospital Transfers” seeks to validate an instrument to measure family-centeredness for children in need of transfer from an Emergency Department to a higher level of care.